Prostate Cancer

Sep 12
3 min read

Prostate Cancer Immunotherapy PROVENGE Shows Median Survival of Nearly 4 Years 

Dendreon Pharmaceuticals PROVENGE (sipuleucel-T) cancer immunotherapy is made from a patients own immune cells for the treatment of prostate cancer
two older men walking across the street
Cancer
Prostate Cancer
+ 2
Sep 11
8 min read

National Prostate Cancer Awareness Focuses on Detection & Treatment

Prostate cancer immunotherapy with Provenge (sipuleucel-T) shows nearly 4 years of survival
older man
Cancer
Prostate Cancer
Aug 27
7 min read

Rice University Invented Prostate Cancer Therapy Excels in Clinical Trial

Gold-silica nanoshell infusion allows for a focused therapy that treats prostate cancer
gold fractual light
Cancer
Prostate Cancer
+ 2
Jun 19
3 min read

Prostate Cancer Treatment Closer to Europe Marketing Approval

Sophiris Bio Topsalysin (PRX302) is a focal therapy to treat patients with intermediate risk, localized prostate cancer
old men talking
Cancer
Prostate Cancer
+ 2
Dec 7
3 min read

Prostate Cancer Vaccine Candidate Limited Disease Progression

ProscaVax prostate cancer vaccine candidate limited cancer progression in 80% of patients
older man
Cancer
Prostate Cancer